155 related articles for article (PubMed ID: 7507536)
1. The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.
Ganten D
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S14-29. PubMed ID: 7507536
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin paradigm. Practical therapeutical consequences of basic research.
Ganten D
Arzneimittelforschung; 1993 Feb; 43(2A):191-7. PubMed ID: 8498963
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
Corvol P; Soubrier F; Jeunemaitre X
Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics methods in the study of hereditary essential hypertension].
Jindra A; Horký K
Cas Lek Cesk; 1998 Jan; 137(2):39-43. PubMed ID: 9511264
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system as a target for therapeutic intervention.
Swales JD
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
[TBL] [Abstract][Full Text] [Related]
7. Transgenic rats: tools to study the function of the renin-angiotensin system.
Bader M; Ganten D
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S81-7. PubMed ID: 8993844
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of antihypertensive treatment.
Arnett DK; Claas SA; Glasser SP
Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
10. Malignant hypertension - the role of the paracrine renin-angiotensin system.
Fleming S
J Pathol; 2000 Oct; 192(2):135-9. PubMed ID: 11004688
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of rennin-angiotensin-aldosterone system genes and NO synthase gene to the development of arterial hypertension].
Savinetskaia GA; Golubeva AA; Pogoda TV; Generozov EV
Klin Med (Mosk); 2008; 86(8):12-7. PubMed ID: 18819340
[TBL] [Abstract][Full Text] [Related]
12. Human genetics, animal models and computer simulations for studying hypertension.
Takahashi N; Smithies O
Trends Genet; 2004 Mar; 20(3):136-45. PubMed ID: 15036807
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
15. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
Gensini GF; Lippi D; Conti AA
Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
[TBL] [Abstract][Full Text] [Related]
16. Genetics of human arterial hypertension.
Naber CK; Siffert W
Minerva Med; 2004 Oct; 95(5):347-56. PubMed ID: 15467511
[TBL] [Abstract][Full Text] [Related]
17. Targeting genes in the renin-angiotensin system.
Le TH; Coffman TM
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):57-63. PubMed ID: 18090671
[TBL] [Abstract][Full Text] [Related]
18. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
19. Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists.
Ménard J
J Hypertens Suppl; 1993 Apr; 11(3):S3-11. PubMed ID: 8315517
[TBL] [Abstract][Full Text] [Related]
20. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
Schunkert H; Holmer SR; Riegger G
Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
